Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section wording was updated to indicate that publications are automatically filled from PubMed and may not be about the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the site-wide government funding notice about information currency and NIH Clinical Center operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedTwo screenshots display the same NCT04126317 CANDELA study record with minor layout variations. Core study details such as objectives, design, eligibility criteria, and outcome measures remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.